Sydney Freedberg

509 posts

Sydney Freedberg banner
Sydney Freedberg

Sydney Freedberg

@spfreedberg

Chief reporter @ICIJ, author, Pulitzer Prize winner. Tips [email protected]

Tampa Bay/Washington D.C. Katılım Kasım 2012
5.8K Takip Edilen977 Takipçiler
Sydney Freedberg retweetledi
Fight For A Living Wage
Fight For A Living Wage@Fight4Wage·
This episode is about Keytruda; we pay significantly more for Keytruda than any other country. What happened to big pharma agreeing to lower drug costs? @usatoday It's about an 11 minute listen, "The blockbuster cancer drug Keytruda can cost over $150,000" youtu.be/r2nlXpED55U?si…
YouTube video
YouTube
Fight For A Living Wage tweet media
English
1
1
3
74
Sydney Freedberg retweetledi
Reporters United
Reporters United@reporters_gr·
#Thread: Νέα δημοσίευση. ❗Ο πρόεδρος του #Eurogroup στο σπίτι της πρέσβειρας του #Τραμπ. 🔸Σιωπή #Πιερρακάκη για την παραθεσμική παρουσία του στην οικία #Γκιλφόιλ με φόντο τα #φάρμακα. 🤝 @ICIJorg ✍️ @dpapageorgiou26 @boublis ✒️ @KasdaglisC @Chondrogiannos 🎨 @spoovio
Reporters United tweet media
Ελληνικά
6
303
497
11.6K
Sydney Freedberg retweetledi
ICIJ
ICIJ@ICIJorg·
ICIJ's #CancerCalculus investigation brought together reporters worldwide to shed new light on strategies Merck & Co. has used to widen the use of its blockbuster cancer drug and protect its monopoly. Here are some of the stories from our media partners: bit.ly/4txgOju
English
0
11
13
2.3K
Sydney Freedberg retweetledi
GIJN en Español
GIJN en Español@gijnEs·
Cancer Calculus del @ICIJorg revela cómo la farmacéutica Merck & Co. ha mantenido precios altos de su medicamento contra el cáncer Keytruda, limitando el acceso de pacientes en todo el mundo. Es un proyecto colaborativo de un año con 47 medios en 37 países twp.ai/4hqG5O
Español
0
11
10
2K
Sydney Freedberg retweetledi
CSRxP
CSRxP@RxPricing·
Big Pharma giant @Merck is engaging in product hopping to game the patent system, delay competition and extend monopoly pricing on its top money-making oncology drug, Keytruda. Get the facts from @ICIJorg and @USATODAY’s analysis:
English
0
2
2
117
Sydney Freedberg retweetledi
Reporters United
Reporters United@reporters_gr·
6⃣ Η διεθνής δημοσιογραφική έρευνα #CancerCalculus του @ICIJorg τεκμηριώνει, με τη συμμετοχή του #ReportersUnited και 46 ακόμη ΜΜΕ, τις πολλαπλές μεθοδεύσεις της αμερικανικής εταιρείας #MSD για τη διατήρηση των υπέρογκων τιμών του #Keytruda, ενός φαρμάκου αποτελεσματικού για πολλές μορφές καρκίνου.
Reporters United tweet media
Ελληνικά
1
60
127
2.4K
Sydney Freedberg
Sydney Freedberg@spfreedberg·
A ‘burgeoning black market’, inflated dosing and the over-judicialization of health care: reporters around the world tell stories about Keytruda - ICIJ icij.org/investigations…
English
0
0
1
41
Sydney Freedberg retweetledi
GIJN Urdu
GIJN Urdu@gijnUrdu·
@ICIJorg کی تازہ ترین بین الاقوامی تحقیقی شراکت، #CancerCalculus، یہ ظاہر کرتی ہے کہ میرک اینڈ کو نے اپنی مشہور کینسر دوا کی ٹرڈا کی قیمت کو غیر معمولی طور پر بلند رکھا جبکہ مسابقت کی حوصلہ شکنی بھی کی۔ twp.ai/4hq5wz
اردو
0
3
4
1.9K
Sydney Freedberg retweetledi
Global Justice Now
Global Justice Now@GlobalJusticeUK·
"With the NHS on its knees, the UK has struck a secretive new drugs deal. But how was it made – and what will it really cost?" Brilliant new investigation from @TBIJ. The new pharma deal is bad for our health, bad for our economy and bad for our NHS. thebureauinvestigates.com/stories/2026-0…
English
1
12
11
340
Sydney Freedberg retweetledi
Katie Robertson
Katie Robertson@katie_robertson·
NEW: The Pittsburgh Post-Gazette will continue publishing! It has been acquired by the nonprofit Venetoulis Institute, which runs the Baltimore Banner. My story here: nytimes.com/2026/04/14/bus…
English
46
885
2.8K
494K
Sydney Freedberg retweetledi
Angelica Peebles
Angelica Peebles@angelicapeebles·
My favorite part of this story is that it shows the role pharma, PBMs and providers all play in the price of Keytruda usatoday.com/story/money/20…
English
0
5
8
3.5K
Sydney Freedberg retweetledi
Pelin Ünker
Pelin Ünker@pelinunker·
Türkiye'de Keytruda gerçeği: Gelir düzeyi tedaviyi karşılamaya yetmiyor SGK geri ödeme listesine alınması tabloyu değiştirmedi. Kapsam sınırlı Geçmişte açılan davalar adeta kangrene dönmüş durumda İlaca da bilgiye de erişim sınırlı @ICIJorg ile yeni araştırma #CancerCalculus
DW Türkçe@dw_turkce

Türkiye'de kanser hastalarını davalık eden ilaç: Keytruda Keytruda tedavisinin yıllık maliyeti 3 milyon lirayı aşıyor Ortalama gelire sahip bir kişi, tedavinin 3 dozunu dahi karşılayamıyor Birçok hasta ilaca ulaşmak için dava açıyor ✍️@pelinunker dw.com/tr/t%C3%BCrkiy…

Türkçe
0
6
15
6.7K